Patent details

91512 Product Name: "Lacosamide et ses dérivés pharmaceutiquement acceptables (VIMPAT®)"

  • Data
  • Documents

Basic Information

Publication number:
91512
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP019662303
Legal Status:
Invalid
Application number:
91512
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/08/470/001-016 Vimpat-lacosamide
Marketing Authorization Type:
Marketing Authorization Date:
29/08/2008
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
14/01/2009
First Marketing Authorization date:
29/08/2008
Grant date:
16/03/2009
Activation date:
Publication date:
16/03/2009
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
29/08/2023
SPC Extension Expiration:
29/08/2023
Rejection date:
Withdrawal date:

Owner

From:
18/02/2009
 
 

Name:
RESEARCH CORPORATION TECHNOLOGIES, INC.
Address:
E.WILLIAMS CIRCLE, SUITE 240 5210, TUCSON, ARIZONA 85711-4410, United States (US)

History of Owners

From:
14/01/2009
To:
17/02/2009

Name:
Research Corporation Technologies Inc
Address:
101 North Wilmot Road, Suite 600, Tucson, Arizona 85711-3335, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
14/01/2009
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
HARRIS Robert, H.
Address:
United States (US)
Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer: